Decreased Level of Creatine Kinase BB in the Frontal Cortex of Alzheimer Patients

Abstract
Complex immunochemical and immunocytochemical investigation of postmortem frontal cortex (area 10) of normal controls and Alzheimer disease (AD) patients revealed a decrease in immunoreactive creatine kinase BB (CK-BB) content in AD. This decrease was not the result of age, postmortem delay, psychotropic therapy or astrocytic destruction. In some AD cases CK-BB was found in neurofibrillary tangles. The possible reasons for these findings are discussed. The decrease of CK-BB level may be important in the pathogenesis of AD because of the consequent energy deficit.

This publication has 0 references indexed in Scilit: